Our work on false-positive mpox results in high-transmission settings is out @thelancetinfdis.bsky.social. Of 2,724 suspected cases in DR Congo, ~35% of qPCR positives (Ct<40) were estimated to be environmentally derived. A Ct cutoff of <34 reduced this to ~5%, with only marginal sensitivity losses

Could existing Ebola vaccines help respond to the current Bundibugyo outbreak in the DRC? A new @thelancetinfdis.bsky.social commentary suggests that deploying Ervebo in high-risk groups could provide protection while generating crucial evidence for future outbreaks www.thelancet.com/journals/lan...

Reconsidering the rVSVΔG-ZEBOV-GP vaccine during the 2026 Bundibugyo virus outbreak

The ongoing 2026 Bundibugyo virus disease (BVD) public health emergency of international concern in DR Congo and Uganda has exposed gaps in preparedness for non-zairense orthoebolaviruses. With BVD va...

thelancet.com

GDD is honored to host SMIDDY's 10th edition, on Thu, Nov 5, 2026 at Campus Biotech, Geneva. Keynotes by Prof. Rachel Lowe (BSC) & Prof. Justin Lessler (UNC Chapel Hill). Seats limited, abstract deadline Sept 4, 2026. Info: sniddy.ch/smiddy_2026/

📢 Our study carried out after the first hepatitis E vaccination campaign in Bentiu, South Sudan shows that the two-dose regimen is effective, supporting its use in similar contexts. #HepatitisE #vaccineswork 💉 @andrewazman.bsky.social www.thelancet.com/journals/lan...

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Despite the small sample size, our estimates provide evidence of effectiveness of a two-dose regimen against HEV genotype 1 during a protracted outbreak, supporting its use in similar contexts.

thelancet.com